HIGHLIGHTS
- who: Anna J. Podolanczuk from the Department of Medicine, Weill Cornell Medical College, York Ave, Box, New York, NY, USA have published the research work: Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial, in the Journal: (JOURNAL)
- what: The Clinical Coordinating Center (CCC) will notify study sites of potential participants Study objective The aim is to compare the effect of NAC plus standard care versus matched placebo plus standard with confirmed TT genotype for potential enrollment into the PRECISIONS trial. This approach has been lacking . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.